Budd Chiari syndrome without evidence for thrombosis. Is it still a Budd Chiari ?
Journal Title: Annals of Hepatology - Year 2009, Vol 8, Issue 4
Abstract
Authors and Affiliations
Sebastian Weis , Christian Wittekind , Christoph Benckert , Joachim Mössner , Henning Wittenburg
The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients
Aim. To evaluate the diagnostic value of dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) in the differential diagnosis of hepatic angiomyolipoma (HAML) and hepatocellular carcinoma...
Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
Introduction. Heparin-induced thrombocytopenia (HIT) is a serious complication seen in hospitalized, medically-ill patients. Evaluation for HIT using a commercially-available ELISA-based test has become increasingly comm...
Prophylactic and curative effects of purslane on bile duct ligation-induced hepatic fibrosis in albino rats
Introduction. Hepatic fibrosis is a common pathological process of chronic liver injury. Oxidative stress and inflammation may have prognostic value in disease progression. Objective. To examine the implication of both a...
Hepatology Highligh
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV
Objectives. Filibuvir is a non-nucleoside inhibitor of hepatitis C virus (HCV) polymerase. This study evaluated the safety and efficacy of filibuvir plus pegylated interferon alfa-2a (pegIFN)/ribavirin. Material and meth...